Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations
06 déc. 2018 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation...
Nuvectra Receives FDA Head-Only MR-Conditional Approval for Algovita®
03 déc. 2018 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration...
Nuvectra® to Participate in Two Upcoming Investor Conferences
31 oct. 2018 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra® Reports Third Quarter 2018 Financial Results
29 oct. 2018 16h01 HE
|
Nuvectra Corporation
Reports Record Algovita® Sales of $12.5 million, Up 98% YoY PLANO, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced...
Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018
22 oct. 2018 08h01 HE
|
Nuvectra Corporation
PLANO, Texas, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra® Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
14 sept. 2018 12h00 HE
|
Nuvectra Corporation
PLANO, Texas, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public...
Nuvectra® Announces Pricing of Follow-On Stock Offering
11 sept. 2018 22h09 HE
|
Nuvectra Corporation
PLANO, Texas, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public...
Nuvectra® Announces Proposed Follow-On Stock Offering
11 sept. 2018 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on...
Nuvectra to Participate in Two Upcoming Investor Conferences
05 sept. 2018 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra™ Reports Second Quarter 2018 Financial Results
07 août 2018 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June...